ITGAX and Insulin resistance: Previous studies have shown that TLR2/4 and JNK signaling pathways play a pivotal role in activating CD11c (+) myeloid proinflammatory cells, which further promotes inflammation and subsequent insulin resistance in cells (Nguyen et al., 2007).